Combined bivalent human papillomavirus vaccine and Candida antigen versus Candida antigen alone in the treatment of recalcitrant warts.
Ayman MareiAhmad NofalRania AlAkadAmina Abdel-HadyPublished in: Journal of cosmetic dermatology (2019)
Bivalent human papillomavirus vaccine combined with Candida antigen is a promising, effective, and safe modality for the treatment of multiple recalcitrant warts.